The Cooper Companies, Inc. (COO) Covered Calls

The Cooper Companies, Inc. is a global medical device company that operates through two primary business units: CooperVision and CooperSurgical. CooperVision focuses on the development and manufacture of a wide range of contact lenses, including specialty products for astigmatism and presbyopia. CooperSurgical provides medical devices and fertility solutions aimed at advancing the health of women, babies, and families through specialized surgical instruments and genetic testing services.

You can sell covered calls on The Cooper Companies, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for COO (prices last updated Fri 4:16 PM ET):

Want to make money with covered calls?  Sign Up For A Free Trial

The Cooper Companies, Inc. is a leading global medical device manufacturer that serves specialty healthcare markets. The company operates through two segments: CooperVision and CooperSurgical. CooperVision is a world leader in the contact lens industry, specializing in high-performance materials and advanced optics. Their portfolio includes daily disposable, two-week, and monthly contact lenses designed to correct visual impairments such as myopia and presbyopia.

CooperSurgical is dedicated to women’s health and fertility. This segment provides a diverse array of medical devices, diagnostic products, and surgical instruments used in hospitals and clinics. Their offerings span from contraceptive devices and surgical tools to advanced genomic testing and cryopreservation services for fertility clinics. By maintaining a focus on these specialized niches, the company has established a robust presence in the global healthcare infrastructure.

Competitive Landscape

The vision care industry is highly competitive, characterized by rapid technological advancements and brand loyalty. CooperVision competes primarily with large multinational firms that have extensive research and development budgets. Key competitors include Alcon, which holds a significant share of the global contact lens market, and Johnson & Johnson, which operates the Acuvue brand. Both of these entities are major players on the NYSE.

In the surgical and fertility markets, CooperSurgical faces competition from various medical technology companies. Prominent rivals in the broader medical device and diagnostics space include Boston Scientific and Abbott Laboratories. While these competitors offer broad portfolios, CooperSurgical maintains an edge through its deep specialization in reproductive health and specialized surgical tools for women’s healthcare providers.

Strategic Outlook and Innovation

The company is focusing its strategic efforts on expanding its presence in the myopia management sector, which represents a growing global health concern. By investing in innovative lens designs that aim to slow the progression of nearsightedness in children, the company is positioning itself at the forefront of a major shift in eye care. This long-term strategy involves close collaboration with eye care professionals to increase adoption of specialty contact lenses.

In the fertility segment, the company continues to integrate advanced genetic screening technologies to improve outcomes for patients. Strategic acquisitions play a vital role in their growth model, allowing them to add complementary products and expand their footprint in international markets. The focus remains on operational efficiency and leveraging their global distribution network to maintain a steady growth trajectory across both core business units.

Want more examples? CONY Covered Calls | COP Covered Calls